Effectiveness of oxaliplatin-based second-line therapy following cetuximab+FOLFIRI or bevacizumab+FOLFIRI in wild-type metastatic colorectal cancer without primary tumor resection
Purpose Wild-type unresectable metastatic colorectal cancer (mCRC) poses challenges for treatment optimization. Effective first-line targeted therapies are crucial for improving outcomes, particularly when combined with second-line oxaliplatin-based chemotherapies. This study examined the effects of...
Shranjeno v:
| Principais autores: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Korean Society of Coloproctology
2025-08-01
|
| Serija: | Annals of Coloproctology |
| Teme: | |
| Online dostop: | http://coloproctol.org/upload/pdf/ac-2025-00087-0012.pdf |
| Oznake: |
Brez oznak, prvi označite!
|